SMTL ID : 8sr0.1

CryoEM structure of a therapeutic antibody (favezelimab) bound to human LAG3 local refined

Coordinates

PDB Format Compare

Method

ELECTRON MICROSCOPY

Oligo State

hetero-2-2-2-mer

Ligands

2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)

NAG.1: 4 residues within 4Å: Chain A: N.188, S.190, F.225 Chain D: E.223 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:N.188, A:S.190 NAG.2: 7 residues within 4Å: Chain A: H.220, L.221, A.222, E.223 Chain D: N.188, S.190, F.225 3 PLIP interactions: 3 interactions with chain D Hydrogen bonds: D:N.188, D:S.190, D:S.190

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Mishra, A.K. et al., CryoEM structure of a therapeutic antibody (favezelimab) bound to human LAG3 determined using a bivalent Fab as fiducial marker. Structure (2023)

Release Date

2023-09-06

Peptides

Lymphocyte activation gene 3 protein: AD
favezelimab Fab heavy chain: BE
favezelimab Fab light chain: CF

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
X

D
D

B
Y

E
H

C
Z

F
L

Lymphocyte activation gene 3 protein

favezelimab Fab heavy chain

favezelimab Fab light chain

Related Entries With Identical Sequence